<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="" /><title>Millinette® 20/75: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="207461.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="207461.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=207461.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2074.htm">7 Obstetrics, gynaecology, and urinary-tract disorders</a> &gt; <a href="4551.htm">7.3 Contraceptives</a> &gt; <a href="4552.htm">7.3.1 Combined hormonal contraceptives</a> &gt; <a href="4553.htm">COMBINED HORMONAL CONTRACEPTIVES</a> &gt; <a href="213842.htm">Oral (low and standard strength)</a> &gt; <a href="36266.htm">Ethinylestradiol with Gestodene</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="4552.htm" title="Previous: 7.3.1 Combined hormonal contraceptives">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4571.htm" title="Next: 7.3.2 Progestogen-only contraceptives">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_4553">COMBINED HORMONAL CONTRACEPTIVES</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i1172.htm" title="Go to appendix 1">Dienogest</a>, <a rel="appendix" href="41001i673.htm" title="Go to appendix 1">Norethisterone</a>, <a rel="appendix" href="41001i665.htm" title="Go to appendix 1">Desogestrel</a>, <a rel="appendix" href="41001i638.htm" title="Go to appendix 1">Ethinylestradiol</a>, <a rel="appendix" href="41001i639.htm" title="Go to appendix 1">Mestranol</a>, <a rel="appendix" href="41001i668.htm" title="Go to appendix 1">Gestodene</a>, <a rel="appendix" href="41001i972.htm" title="Go to appendix 1">Norelgestromin</a>, <a rel="appendix" href="41001i962.htm" title="Go to appendix 1">Drospirenone</a>, <a rel="appendix" href="41001i674.htm" title="Go to appendix 1">Norgestimate</a>, <a rel="appendix" href="41001i671.htm" title="Go to appendix 1">Levonorgestrel</a>, <a rel="appendix" href="41001i890.htm" title="Go to appendix 1">Etonogestrel</a>, <a rel="appendix" href="41001i640.htm" title="Go to appendix 1">Estradiol</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">contraception; menstrual
symptoms (<a title=" Progestogens" href="4336.htm#_4336">section
6.4.1.2</a>)</p></div><div class="cAF" id="_4553.7"><h2>Cautions</h2> <p class="cAF">see <a title="sub-section: Combined hormonal contraceptives" href="4552.htm#_4552">notes above</a>; risk factors for venous thromboembolism (see below
and also <a title="target-block: contraceptives and risk of venous thromboembolism" href="4552.htm#_4552.5">notes above</a>), arterial
disease and migraine, see below<span id="_4553.22">; personal or family history of hypertriglyceridaemia
(increased risk of pancreatitis); hyperprolactinaemia
(seek specialist advice); history of severe
depression especially if induced by hormonal contraceptive; undiagnosed breast mass; gene mutations associated with breast cancer (e.g.
BRCA 1); sickle-cell disease; inflammatory bowel disease including Crohn’s
disease; reduced efficacy of contraceptive
patch in women with body-weight ≥ 90 kg; active trophoblastic disease (until return to normal of urine- and
plasma-gonadotrophin concentration)—seek specialist advice; <b>interactions:</b> <a title="target-block: COCs interactions" href="4552.htm#_120026">see above</a> and Appendix 1 (oestrogens, progestogens)</span></p><div class="cAV"><h3>Risk factors for venous thromboembolism</h3> <p>See also <a title="target-block: contraceptives and risk of venous thromboembolism" href="4552.htm#_4552.5">notes above</a>. Use with <b>caution</b> if any of following factors present but <b>avoid</b> if two or more factors present:</p><ul class="cBF"><li><p class="cQ"><span id="_4553.4"><i>family
history of venous thromboembolism</i> in first-degree relative
aged under 45 years (avoid contraceptive containing
desogestrel or gestodene, <i>or</i> avoid if known prothrombotic coagulation abnormality e.g. factor V Leiden
or antiphospholipid antibodies (including lupus anticoagulant))</span>;</p></li><li><p class="cQ"><span id="_4553.8"><i>obesity</i>—body mass index ≥ 30 kg/m<sup>2</sup> (avoid if body mass index ≥ 35 kg/m<sup>2</sup> unless no suitable
alternative);</span></p></li><li><p class="cQ"><span id="_4553.9"><i>long-term
immobilisation</i> e.g. in a wheelchair (avoid
if confined to bed or leg in plaster
cast);</span></p></li><li><p class="cQ"><span id="_4553.10"><i>history
of superficial thrombophlebitis</i>;</span></p></li><li><p class="cQ"><i>age</i> over 35 years (avoid if over 50 years);</p></li><li><p class="cQ"><i>smoking</i>.</p></li></ul></div><div id="_4553.11"><div class="cAV"><h3>Risk factors for arterial disease</h3> <p>Use with <b>caution</b> if any one of following factors present but <b>avoid</b> if two or more factors present:</p><ul class="cBF"><li><p class="cQ"><i>family history of arterial disease</i> in first degree relative aged under 45 years (avoid
if atherogenic lipid profile);</p></li><li><p class="cQ"><i>diabetes mellitus</i> (avoid if diabetes complications present);</p></li><li><p class="cQ"><i>hypertension</i>—blood pressure
above <i>systolic 140 mmHg</i> or <i>diastolic 90 mmHg</i> (avoid if blood pressure above <i>systolic 160 mmHg</i> or <i>diastolic 95 mmHg</i>);</p></li><li><p class="cQ"><i>smoking</i> (avoid
if smoking 40 or more cigarettes daily);</p></li><li><p class="cQ"><i>age</i> over 35 years (avoid if over 50 years);</p></li><li><p class="cQ"><i>obesity</i> (avoid
if body mass index ≥ 35 kg/m<sup>2</sup> unless
no suitable alternative);</p></li><li><p class="cQ"><i>migraine without aura </i>(avoid if <i>migraine with aura </i>(focal symptoms), <i>or</i> severe migraine frequently lasting
over 72 hours despite treatment,<i> or </i>migraine treated with ergot derivatives).</p></li></ul></div><div class="cAV"><h3>Migraine</h3> <p class="cAX">Women should report any increase in headache
frequency or onset of focal symptoms (discontinue immediately and
refer urgently to neurology expert if focal neurological symptoms
not typical of aura persist for more than 1 hour—see also <a title="target-block: hrt reasons to stop" href="4552.htm#_120027">Reason To Stop Immediately</a> in notes above)</p></div></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">see <a title="sub-section: Combined hormonal contraceptives" href="4552.htm#_4552">notes above</a>; <span id="_4553.2">personal history of venous or arterial thrombosis, severe or multiple risk factors for arterial disease or for venous
thromboembolism (see above), heart disease associated with
pulmonary hypertension or risk of embolus; sclerosing treatment for varicose veins; migraine with
aura (see also <a title="target-block: COC cautions (b)" href="4553.htm#_4553.11">above</a>); transient cerebral ischaemic
attacks without headaches; systemic lupus erythematosus
with (or unknown) antiphospholipid antibodies; acute porphyria (<a title=" Acute porphyrias" href="5181.htm#_5181">section 9.8.2</a>); gallstones; history of haemolytic uraemic syndrome or history during
pregnancy of pruritus, cholestatic jaundice, chorea, pemphigoid gestationis;
history of breast cancer but can be used after 5 years if no evidence
of disease and non-hormonal methods unacceptable; undiagnosed vaginal
bleeding</span><span id="_200582"></span><span id="_4553.15"></span></p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">avoid in active liver disease including disorders of
hepatic excretion (e.g. Dubin-Johnson or Rotor syndromes), infective
hepatitis (until liver function returns to normal), and liver tumours</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">not known to be harmful</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">avoid until weaning or for 6 months after birth
(adverse effects on lactation)</p></div><div class="cAF" id="_215765"><h2>Side-effects</h2> <p class="cAF">see <a title="sub-section: Combined hormonal contraceptives" href="4552.htm#_4552">notes above</a>; also nausea,
vomiting, abdominal cramps, liver impairment, hepatic tumours; fluid
retention, thrombosis (more common when factor V Leiden present or
in blood groups A, B, and AB; see also notes above), hypertension,
changes in lipid metabolism; headache, depression, chorea, nervousness,
irritability; changes in libido, breast tenderness, enlargement, and
secretion; reduced menstrual loss, ‘spotting’ in early cycles, absence
of withdrawal bleeding, amenorrhoea after discontinuation, changes
in vaginal discharge, cervical erosion; contact lenses may irritate,
visual disturbances; leg cramps; skin reactions, chloasma, photosensitivity;
rarely gallstones and systemic lupus erythematosus</p><div class="cAV"><h3>Breast cancer</h3> <p class="cAX">There is a small increase in the
risk of having breast cancer diagnosed in women taking the combined
oral contraceptive pill; this relative risk may be due to an earlier
diagnosis. In users of combined oral contraceptive pills the cancers
are more likely to be localised to the breast. The most important
factor for diagnosing breast cancer appears to be the age at which
the contraceptive is stopped rather than the duration of use; any
increase in the rate of diagnosis diminishes gradually during the
10 years after stopping and disappears by 10 years</p></div><div class="cAV"><h3>Cervical cancer</h3> <p class="cAX">Use of combined oral contraceptives
for 5 years or longer is associated with a small increased risk of
cervical cancer; the risk diminishes after stopping and disappears
by about 10 years. The risk of cervical cancer with transdermal patches
and vaginal rings is not yet known</p></div><div class="cAV"><h3>Note</h3> <p class="cAX">The possible small increase in the risk of
breast cancer and cervical cancer should be weighed against the protective
effect against cancers of the ovary and endometrium</p></div></div><div class="cAF"><h2>Dose</h2> <div id="_207457"><p><span class="cU">By
mouth</span>, each tablet should be taken at approximately
same time each day; if delayed, contraceptive protection may be lost
(see <a title="BNF:target-block: Missed pill" href="4552.htm#_4552.4">missed pill</a>)</p><p><i>21-day combined (monophasic) preparations</i>,
1 tablet daily for 21 days; subsequent courses repeated after a 7-day
interval (during which withdrawal bleeding occurs); if reasonably
certain woman is not pregnant, first course can be started on any
day of cycle—if starting on day 6 of cycle or later, additional precautions
(barrier methods) necessary during first 7 days</p><p><i>Every day (ED) combined (monophasic) preparations</i>, 1 <i>active</i> tablet daily for 21 days, followed by
1 <i>inactive</i> tablet daily for 7 days (see also Combined
Oral Contraceptives <a title="BNF:preparation-family: Oral (low and standard strength)" href="213842.htm#_213842">table</a>, below); subsequent
courses repeated without interval (withdrawal bleeding occurs when <i>inactive</i> tablets being taken); if reasonably certain woman
is not pregnant, first course can be started on any day of cycle—if
starting on day 6 of cycle or later, additional precautions (barrier
methods) necessary during first 7 days</p><p><i>Phasic preparations</i>, see Combined Oral Contraceptives <a title="BNF:preparation-family: Oral (low and standard strength)" href="213842.htm#_213842">table</a>, below</p><div class="cAT"><h3>Changing to combined preparation containing different progestogen</h3> <p class="cAX">If previous contraceptive used correctly, or pregnancy can reasonably
be excluded, start the first <i>active</i> tablet of new
brand immediately</p><p><i>Changing to Qlaira®</i>: start the first<i> active Qlaira®</i> tablet on the day after taking the last
active tablet of the previous brand</p><p><i>Changing from Qlaira®</i>: start the new brand
after taking the last active <i>Qlaira®</i> tablet; if the
inactive tablets are taken before starting new brand, additional precautions
(barrier methods) should be used during first 7 days of taking the
new brand</p></div><div class="cAT"><h3>Changing from progestogen-only tablet</h3> <p class="cAX">If previous
contraceptive used correctly, or pregnancy can reasonably be excluded,
start new brand immediately, additional precautions (barrier methods)
necessary for first 7 days</p><p><i>Changing to Qlaira®</i>: start any day, additional
precautions (barrier methods) necessary for first 9 days</p></div><div class="cAT"><h3>Secondary amenorrhoea (exclude pregnancy)</h3> <p class="cAX">Start
any day, additional precautions (barrier methods) necessary during
first 7 days (9 days for <span class="cZ">Qlaira</span>®)</p></div><div class="cAT"><h3>After childbirth (not breast-feeding)</h3> <p class="cAX">Start 3
weeks after birth (increased risk of thrombosis if started earlier);
later than 3 weeks postpartum additional precautions (barrier methods)
necessary for first 7 days (9 days for <span class="cZ">Qlaira</span>®)</p></div><div class="cAT"><h3>After abortion or miscarriage</h3> <p class="cAX">Start same day</p></div></div><div id="_207458"><p><span class="cU">By transdermal application</span>, apply first
patch on day 1 of cycle, change patch on days 8 and 15; remove third
patch on day 22 and apply new patch after 7-day patch-free interval
to start subsequent contraceptive cycle</p><div class="cAT"><h3>Note</h3> <p class="cAX">If first patch applied later than day 1,
additional precautions (barrier methods) should be used for the next
7 days</p></div><div class="cAT"><h3>Changing from combined oral contraception</h3> <p class="cAX">Apply
patch on the first day of withdrawal bleeding; if no withdrawal bleeding
within 5 days of taking last <i>active</i> tablet, rule
out pregnancy before applying first patch. Unless patch is applied
on first day of withdrawal bleeding, additional precautions (barrier
methods) should be used concurrently for first 7 days</p></div><div class="cAT"><h3>Changing from progestogen-only method</h3> <p class="cAX">From an
implant, apply first patch on the day implant removed; from an injection,
apply first patch when next injection due; from oral progestogen,
first patch may be applied on any day after stopping pill. For all
methods additional precautions (barrier methods) should be used concurrently
for first 7 days </p></div><div class="cAT"><h3>After childbirth (not breast-feeding)</h3> <p class="cAX">Start 4
weeks after birth; if started later than 4 weeks after birth additional
precautions (barrier methods) should be used for first 7 days</p></div><div class="cAT"><h3>After abortion or miscarriage</h3> <p class="cAX">Before 20 weeks’
gestation start immediately; no additional contraception required
if started immediately. After 20 weeks’ gestation start on day 21
after abortion or on the first day of first spontaneous menstruation;
additional precautions (barrier methods) should be used for first
7 days after applying the patch</p></div></div><div id="_207459"><p><span class="cU">By vagina</span>, insert ring into vagina on day 1 of cycle and
leave in for 3 weeks; remove ring on day 22; subsequent courses repeated
after 7-day ring-free interval (during which withdrawal bleeding occurs) </p><div class="cAT"><h3>Note</h3> <p class="cAX">If first ring inserted later than day 1,
additional precautions (barrier methods) should be used for the next
7 days</p></div><div class="cAT"><h3>Changing from combined hormonal contraception</h3> <p class="cAX">Insert ring at the latest on the day after the usual tablet-free,
patch-free, or inactive-tablet interval. If previous contraceptive
used correctly, or pregnancy can reasonably be excluded, can switch
to ring on any day of cycle</p></div><div class="cAT"><h3>Changing from progestogen-only method</h3> <p class="cAX">From an
implant or intra-uterine progestogen-only device, insert ring on the
day implant or intra-uterine progestogen-only device removed; from
an injection, insert ring when next injection due; from oral preparation,
first ring may be inserted on any day after stopping pill. For all
methods additional precautions (barrier methods) should be used concurrently
for first 7 days</p></div><div class="cAT"><h3>After first trimester abortion</h3> <p class="cAX">Start immediately</p></div><div class="cAT"><h3>After childbirth (not breast-feeding) or second trimester abortion</h3> <p class="cAX">Start 4 weeks after birth or abortion; if started later than
4 weeks after birth or abortion, additional precautions (barrier methods)
should be used for first 7 days</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><h1 class="title">Oral (low and standard strength)</h1><p>For information on these preparations, see Combined Oral Contraceptives
table</p><div class="cBM" id="_tb0065">Combined Oral Contraceptives</div><table class="table" summary="Combined Oral Contraceptives" cellspacing="0" cellpadding="8" width="100%" border="0" style="border-collapse: collapse;border-top: 1pt solid ; border-bottom: 1pt solid ; border-left: 1pt solid ; border-right: 1pt solid ; "><colgroup><col /><col /><col /><col /><col /><col /><col /></colgroup><thead><tr style="border-bottom: 1pt solid ; "><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; " colspan="7"><b>See</b> <b><a title="BNF:target-block: contraceptives and risk of venous thromboembolism" href="4552.htm#_4552.5">Risk of Venous Thromboembolism</a></b><b> (in notes above) before prescribing</b></th></tr><tr style="border-bottom: 1pt solid ; "><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Type of preparation</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Oestrogen content</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Progestogen content</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Tablets per cycle</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Brand</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Price, 3-cycle pack (unless stated)</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Manufacturer</th></tr></thead><tbody><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="6"><sup class="footnote"><a title="Go to footnote" href="207461.htm#footnote213851">(1)</a></sup>Monophasic low strength (21-day preparations)</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="6">Ethinylestradiol 20 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">Desogestrel 150 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Gedarel® 20/150</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£5.98</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Consilient</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Mercilon®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£7.97</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Organon</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">Gestodene 75 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Femodette®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£8.85</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Bayer</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Millinette® 20/75</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£6.37</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Consilient</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Sunya 20/75®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£6.62</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Stragen</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norethisterone acetate 1 mg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Loestrin 20®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£2.85</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Galen</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="16"><sup class="footnote"><a title="Go to footnote" href="207461.htm#footnote213851">(1)</a></sup>Monophasic standard strength (21-day preparations)</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="11">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">Desogestrel 150 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Gedarel® 30/150</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£4.93</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Consilient</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Marvelon®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£6.45</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Organon</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Drospirenone 3 mg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><sup class="footnote"><a title="Go to footnote" href="207461.htm#footnote213853">(2)</a></sup><b>Yasmin®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£14.70</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Bayer</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">Gestodene 75 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Femodene®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£6.73</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Bayer</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Katya 30/75®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£5.03</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Stragen</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Millinette® 30/75</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£4.85</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Consilient</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4">Levonorgestrel 150 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Levest®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£3.00</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Morningside</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Microgynon 30®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£2.82</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Bayer</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Ovranette®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£2.20</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Wyeth</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Rigevidon®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£1.89</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Consilient</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norethisterone acetate 1.5 mg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Loestrin 30®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£3.99</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Galen</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norgestimate 250 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Cilest®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">3-cycle pack = £5.63;<br />6-cycle pack = £11.26</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Janssen</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">Norethisterone 500 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Brevinor®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£1.99</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Pharmacia</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Ovysmen®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£1.89</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Janssen</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norethisterone 1 mg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Norimin®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£2.28</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Pharmacia</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Mestranol 50 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norethisterone 1 mg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">21</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Norinyl-1®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£2.19</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Pharmacia</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4"><sup class="footnote"><a title="Go to footnote" href="207461.htm#footnote213852">(3)</a></sup>Monophasic standard strength (28-day ‘<i>Every day</i>’ preparations)</td><td style="border-right: 1pt solid ; ">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; ">Gestodene 75 micrograms</td><td style="border-right: 1pt solid ; ">21 active</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2"><b>Femodene® ED</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">£7.10</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">Bayer</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">7 inactive</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; ">Levonorgestrel 150 micrograms</td><td style="border-right: 1pt solid ; ">21 active</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2"><b>Microgynon 30 ED®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">£2.99</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">Bayer</td></tr><tr style="border-bottom: 1pt solid ; "><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">7 inactive</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="15"><sup class="footnote"><a title="Go to footnote" href="207461.htm#footnote213851">(1)</a></sup>Phasic standard strength (21-day preparations)</td><td style="border-right: 1pt solid ; ">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; ">Gestodene 50 micrograms</td><td style="border-right: 1pt solid ; ">6</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3"><b>Triadene®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">£10.40</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">Bayer</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 40 micrograms</td><td style="border-right: 1pt solid ; ">Gestodene 70 micrograms</td><td style="border-right: 1pt solid ; ">5</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Gestodene 100 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">10</td></tr><tr><td style="border-right: 1pt solid ; " rowspan="2">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; " rowspan="2">Levonorgestrel 50 micrograms</td><td style="border-right: 1pt solid ; " rowspan="2">6</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "><b>Logynon®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">£3.96</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Bayer</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3"><b>TriRegol®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">£2.87</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">Consilient</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 40 micrograms</td><td style="border-right: 1pt solid ; ">Levonorgestrel 75 micrograms</td><td style="border-right: 1pt solid ; ">5</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Levonorgestrel 125 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">10</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; ">Norethisterone 500 micrograms</td><td style="border-right: 1pt solid ; ">7</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2"><b>BiNovum®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">£2.49</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="2">Janssen</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norethisterone 1 mg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">14</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; ">Norethisterone 500 micrograms</td><td style="border-right: 1pt solid ; ">7</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3"><b>Synphase®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">1-cycle pack = £1.20</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">Pharmacia</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; ">Norethisterone 1 mg</td><td style="border-right: 1pt solid ; ">9</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norethisterone 500 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">5</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; ">Norethisterone 500 micrograms</td><td style="border-right: 1pt solid ; ">7</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3"><b>TriNovum®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">£3.46</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="3">Janssen</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; ">Norethisterone 750 micrograms</td><td style="border-right: 1pt solid ; ">7</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Ethinylestradiol 35 micrograms</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">Norethisterone 1 mg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">7</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4"><sup class="footnote"><a title="Go to footnote" href="207461.htm#footnote213852">(3)</a></sup>Phasic standard strength (28-day ‘<i>Every day</i>’ preparation)</td><td style="border-right: 1pt solid ; ">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; ">Levonorgestrel 50 micrograms</td><td style="border-right: 1pt solid ; ">6 active</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4"><b>Logynon ED®</b></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4">£4.00</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="4">Bayer</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 40 micrograms</td><td style="border-right: 1pt solid ; ">Levonorgestrel 75 micrograms</td><td style="border-right: 1pt solid ; ">5 active</td></tr><tr><td style="border-right: 1pt solid ; ">Ethinylestradiol 30 micrograms</td><td style="border-right: 1pt solid ; ">Levonorgestrel 125 micrograms</td><td style="border-right: 1pt solid ; ">10 active</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">7 inactive</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="5"><sup class="footnote"><a title="Go to footnote" href="207461.htm#footnote215528">(4)</a></sup>Phasic (28-day ‘<i>Every day</i>’ preparation)</td><td style="border-right: 1pt solid ; ">Estradiol valerate 3 mg</td><td style="border-right: 1pt solid ; "> </td><td style="border-right: 1pt solid ; ">2 active</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="5"><b>Qlaira®</b><a href="204285.htm" title="Report adverse reaction(s)"><img class="cK" src="images/blacktri_l.png" alt="Black triangle" /></a></td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="5">£25.18</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; " rowspan="5">Bayer</td></tr><tr><td style="border-right: 1pt solid ; ">Estradiol valerate 2 mg</td><td style="border-right: 1pt solid ; ">Dienogest 2 mg</td><td style="border-right: 1pt solid ; ">5 active</td></tr><tr><td style="border-right: 1pt solid ; ">Estradiol valerate 2 mg</td><td style="border-right: 1pt solid ; ">Dienogest 3 mg</td><td style="border-right: 1pt solid ; ">17 active</td></tr><tr><td style="border-right: 1pt solid ; ">Estradiol valerate 1 mg</td><td style="border-right: 1pt solid ; "> </td><td style="border-right: 1pt solid ; ">2 active</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; "> </td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; ">2 inactive</td></tr></tbody></table><ul><li id="_36262__36262"><a href="36262.htm#_36262" title="Ethinylestradiol with Levonorgestrel">Ethinylestradiol with Levonorgestrel</a><ul style="display: none"><li><a href="207488.htm#_207488" title="Levest®">Levest®</a></li><li><a href="34690.htm#_34690" title="Logynon®">Logynon®</a></li><li><a href="34691.htm#_34691" title="Logynon ED®">Logynon ED®</a></li><li><a href="34579.htm#_34579" title="Microgynon 30®">Microgynon 30®</a></li><li><a href="61010.htm#_61010" title="Microgynon 30 ED®">Microgynon 30 ED®</a></li><li><a href="34586.htm#_34586" title="Ovranette®">Ovranette®</a></li><li><a href="207463.htm#_207463" title="Rigevidon®">Rigevidon®</a></li><li><a href="207464.htm#_207464" title="TriRegol®">TriRegol®</a></li></ul></li><li id="_36263__36263"><a href="36263.htm#_36263" title="Ethinylestradiol with Norethisterone">Ethinylestradiol with Norethisterone</a><ul style="display: none"><li><a href="34694.htm#_34694" title="BiNovum®">BiNovum®</a></li><li><a href="34594.htm#_34594" title="Brevinor®">Brevinor®</a></li><li><a href="34563.htm#_34563" title="Loestrin 20®">Loestrin 20®</a></li><li><a href="34591.htm#_34591" title="Loestrin 30®">Loestrin 30®</a></li><li><a href="34610.htm#_34610" title="Norimin®">Norimin®</a></li><li><a href="34608.htm#_34608" title="Ovysmen®">Ovysmen®</a></li><li><a href="34695.htm#_34695" title="Synphase®">Synphase®</a></li><li><a href="34696.htm#_34696" title="TriNovum®">TriNovum®</a></li></ul></li><li id="_36264__36264"><a href="36264.htm#_36264" title="Ethinylestradiol with Norgestimate">Ethinylestradiol with Norgestimate</a><ul style="display: none"><li><a href="34598.htm#_34598" title="Cilest®">Cilest®</a></li></ul></li><li id="_36260__36260"><a href="36260.htm#_36260" title="Ethinylestradiol with Desogestrel">Ethinylestradiol with Desogestrel</a><ul style="display: none"><li><a href="207460.htm#_207460" title="Gedarel® 20/150">Gedarel® 20/150</a></li><li><a href="207469.htm#_207469" title="Gedarel® 30/150">Gedarel® 30/150</a></li><li><a href="34560.htm#_34560" title="Mercilon®">Mercilon®</a></li><li><a href="34566.htm#_34566" title="Marvelon®">Marvelon®</a></li></ul></li><li id="_106498__106498"><a href="106498.htm#_106498" title="Ethinylestradiol with Drospirenone">Ethinylestradiol with Drospirenone</a><ul style="display: none"><li><a href="106471.htm#_106471" title="Yasmin®">Yasmin®</a></li></ul></li><li><h1 class="title">Ethinylestradiol with Gestodene</h1><ul><li><a href="34573.htm#_34573" title="Femodene®">Femodene®</a></li><li><a href="34574.htm#_34574" title="Femodene® ED">Femodene® ED</a></li><li><a href="82302.htm#_82302" title="Femodette®">Femodette®</a></li><li><a href="200136.htm#_200136" title="Katya 30/75®">Katya 30/75®</a></li><li class="jN" id="_207461" style="margin: 0 0 0 20px;"><h1 class="title">Millinette® 20/75<span> (<a href="appendix-112803-C.htm#m207349">Consilient</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><p>For further information on this preparation, see <a title="BNF:preparation-family: Oral (low and standard strength)" href="213842.htm#_213842">table</a></p></li><li><a href="207470.htm#_207470" title="Millinette® 30/75">Millinette® 30/75</a></li><li><a href="200135.htm#_200135" title="Sunya 20/75®">Sunya 20/75®</a></li><li><a href="34687.htm#_34687" title="Triadene®">Triadene®</a></li></ul></li><li id="_36268__36268"><a href="36268.htm#_36268" title="Mestranol with Norethisterone">Mestranol with Norethisterone</a><ul style="display: none"><li><a href="34606.htm#_34606" title="Norinyl-1®">Norinyl-1®</a></li></ul></li><li><a href="82303.htm#_82303" title="Ethinylestradiol with cyproterone acetate">Ethinylestradiol with cyproterone acetate</a></li><li id="_202764__202764"><a href="202764.htm#_202764" title="Estradiol valerate with Dienogest">Estradiol valerate with Dienogest</a><ul style="display: none"><li><a href="202765.htm#_202765" title="Qlaira®">Qlaira®</a></li></ul></li></ul></li><li id="_128116__128116"><a href="128116.htm#_128116" title="Transdermal (standard strength)">Transdermal (standard strength)</a><ul style="display: none"><li id="_127951__127951"><a href="127951.htm#_127951" title="Ethinylestradiol with Norelgestromin">Ethinylestradiol with Norelgestromin</a><ul style="display: none"><li><a href="127952.htm#_127952" title="Evra®">Evra®</a></li></ul></li></ul></li><li id="_202423__202423"><a href="202423.htm#_202423" title="Vaginal (low strength)">Vaginal (low strength)</a><ul style="display: none"><li id="_202424__202424"><a href="202424.htm#_202424" title="Ethinylestradiol with Etonogestrel">Ethinylestradiol with Etonogestrel</a><ul style="display: none"><li><a href="202425.htm#_202425" title="NuvaRing®">NuvaRing®</a></li></ul></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="4552.htm">Previous: 7.3.1 Combined hormonal contraceptives</a> | <a class="top" href="207461.htm#">Top</a> | <a accesskey="]" href="4571.htm">Next: 7.3.2 Progestogen-only contraceptives</a> ►</div><div class="cF"><div class="footnote" id="footnote213851"><sup>(1)</sup><i>Dose</i> 1 tablet daily for 21 days starting on
day 1–5 of cycle (if reasonably certain woman is not pregnant, first
course can be started on any day of cycle); subsequent courses repeated
after 7-day tablet-free interval (during which withdrawal bleeding
occurs); for starting routines see under <a title="BNF:target-block: Dose- combined hormonal contraceptive preps" href="4553.htm#_207457">Dose</a> above</div><div class="footnote" id="footnote213853"><sup>(2)</sup><i>Caution</i> use with care if increased plasma-potassium
concentration might be hazardous; <i>renal impairment</i> avoid if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></div><div class="footnote" id="footnote213852"><sup>(3)</sup><i>Dose</i> 1 tablet daily for 28 days starting on
day 1–5 of cycle with first active tablet (withdrawal bleeding occurs
when inactive tablets being taken) (if reasonably certain woman is
not pregnant, first course can be started on any day of cycle); subsequent
courses repeated without interval; for starting routines see under <a title="BNF:target-block: Dose- combined hormonal contraceptive preps" href="4553.htm#_207457">Dose</a> above</div><div class="footnote" id="footnote215528"><sup>(4)</sup><i>Dose</i> 1 tablet daily for 28 days starting on
day 1 of cycle with first active tablet (withdrawal bleeding occurs
when inactive tablets being taken); subsequent courses repeated without
interval; for starting routines see under <a title="BNF:target-block: Dose- combined hormonal contraceptive preps" href="4553.htm#_207457">Dose</a> above</div></div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>